INOCARD
InoCard is a biotechnology company and develops AAV-based gene therapy approach for the long-term treatment of congestive heart failure, targeting the calcium-binding protein S100A1.
INOCARD
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2013-01-01
Address:
Heidelberg, Baden-Wurttemberg, Germany
Country:
Germany
Status:
Active
Similar Organizations
Cardiola
Cardiola is a biotechnology company developing therapeutic systems for the treatment of chronic heart failure.
NeuroTargets
NeuroTargets is a biotechnology company that researches and develops drugs for the treatment of neurological diseases.